Preparations include expanding the Ionis Every Step patient support program and finalizing a targeted sales force. Data from the ESSENCE safety study for olezarsen in sHTG is expected in Q2 ...

Shareholders in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. Consensus estimates suggest ...

CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $147 million in its first quarter. The Carlsbad, California-based company said ...